Our advertisers

Milton Pharmaceuticals Co UK Ltd
ParAid
Armstrong Medical
CliniMed Limited
Nutricia Ltd
Medela AG
Baxter Healthcare Ltd
Vygon (UK) Ltd
Solus Medical Limited
Inspiration Healthcare
vCreate Neonatal
University of Plymouth
Central Medical Supplies Ltd
The Brazelton Centre UK
Intersurgical Ltd

 

 

Volume 15/Issue 1, January 2019

Failed diagnosis of GBS in newborns costs the NHS millions in negligence claims

Oliver Plumb


Newborn babies are needlessly dying or being left with potentially life-changing disabilities because the NHS is failing to prevent or treat infection caused by group B Streptococcus (GBS) at birth, which kills one baby in the UK each week. This failure is costing the NHS millions in negligence claims.

Abbreviated: Please subscribe and log in to see the full article.

 
© Copyright of Stansted News Limited 2019. Terms & Conditions of reading. Privacy policy